HIGHFDA DRUG

Sucralfate Tablets Recall Expanded After CGMP Deviations; 26,992 Blister Packs Affected

A recall is active for Sucralfate Tablets, USP 1 gram distributed by American Health Packaging. The firm filed for Chapter 11 in September 2024, triggering CGMP deviations and questions about product identity, strength, quality and purity. The recall affects 26,992 blister packs distributed nationwide. Stop using the product and contact Amerisource Health Services or your clinician for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
July 29, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
July 29, 2025
Hazard Level
HIGH
Brands
SUCRALFATE, American Health Packaging
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PREGNANT

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
SUCRALFATE, American Health Packaging
Product type
Sucralfate Tablets
Model numbers
Lot 1015038, Lot 1015898, Lot 1016873, Lot 1023398
UPC codes
60687-695, 60687-695-11, 60687-695-01
Sizes
1 gram tablets
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    July 29, 2025

  2. Reported by FDA DRUG

    September 3, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Amerisource Health Services LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Sucralfate tablets are used to treat ulcers and gastritis by creating a protective barrier in the stomach.

Why This Is Dangerous

CGMP deviations mean the product identity, strength, quality and purity cannot be assured, potentially exposing patients to adulterated medication.

Industry Context

This recall is not described as part of a broader industry pattern in the summary.

Real-World Impact

Consumers may face ineffective treatment due to adulterated product and potential safety concerns; affected patients should contact providers for guidance.

Practical Guidance

How to identify if yours is affected

  1. Check NDC 60687-695-01 on carton and 60687-695-11 on unit dose
  2. Confirm packaging shows distributor American Health Packaging, Columbus, OH

Where to find product info

FDA recall page and enforcement report D-0598-2025 at accessdata.fda.gov

What timeline to expect

Refunds or replacements coordinated by Amerisource Health Services LLC; timelines not specified

If the manufacturer is unresponsive

  • Escalate to FDA MedWatch if manufacturer is unresponsive
  • Consult healthcare provider for interim treatment guidance

How to prevent similar issues

  • Verify CGMP compliance before purchasing drugs
  • Check for recalls on FDA recalls database
  • Buy from reputable pharmacies with clear lot tracking

Documentation advice

Keep recall notification letters, product packaging, lot numbers, and correspondence with healthcare providers

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Sucralfate Tablets, USP 1 gram, 100 tablets per package (10x10). Distributor: American Health Packaging, Columbus, OH 43217. NDC 60687-695-01 carton; Unit Dose NDC 60687-695-11. Quantity recalled: 26,992 blister packs. Distribution: Nationwide. Classification: Class II. Recall date: 2025-07-29. Status: Active.

Reported Incidents

No specific injuries or incidents are described in the notice. The recall notice uses regulatory language rather than incident counts.

Key Facts

  • 26,992 blister packs recalled
  • CGMP Deviations cited due to Chapter 11 filing

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPREGNANTPREGNANTGENERAL
Injury Types
ELECTRICALLACERATIONPOISONINGOTHER

Product Details

Model Numbers
Lot 1015038
Lot 1015898
Lot 1016873
Lot 1023398
UPC Codes
60687-695
60687-695-11
60687-695-01
Affected States
ALL
Report Date
September 3, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

KVK-Tech Inc. Recalls Oxycodone Hydrochloride Tablets Over Seal Defects

KVK-Tech Inc. recalled 31,676 packages of Oxycodone Hydrochloride Tablets on January 14, 2026. Defective seals may cause tablets to fall out, posing a health risk. Customers should stop using the product immediately and seek guidance from healthcare providers.

OXYCODONE HYDROCHLORIDE
Defective container:
Read more